Cas no 198205-83-3 ([1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester)
[1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester Chemical and Physical Properties
Names and Identifiers
-
- [1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester
- methyl 4-[3,5-bis(trifluoromethyl)phenyl]benzoate
- AKOS004116985
- 198205-83-3
- SCHEMBL2389365
- WRGVQDJLLLWQTJ-UHFFFAOYSA-N
- methyl4-[3,5-bis(trifluoromethyl)phenyl]benzoate
-
- Inchi: 1S/C16H10F6O2/c1-24-14(23)10-4-2-9(3-5-10)11-6-12(15(17,18)19)8-13(7-11)16(20,21)22/h2-8H,1H3
- InChI Key: WRGVQDJLLLWQTJ-UHFFFAOYSA-N
- SMILES: C1(C2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)=CC=C(C(OC)=O)C=C1
Computed Properties
- Exact Mass: 348.05849853Da
- Monoisotopic Mass: 348.05849853Da
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 8
- Heavy Atom Count: 24
- Rotatable Bond Count: 3
- Complexity: 415
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 5.7
- Topological Polar Surface Area: 26.3?2
[1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD00846923-1g |
Methyl 4-[3,5-bis(trifluoromethyl)phenyl]benzoate |
198205-83-3 | 95% | 1g |
¥3059.0 | 2023-01-30 |
[1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester Related Literature
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
-
Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
-
Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
Additional information on [1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester
Introduction to [1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester (CAS No. 198205-83-3)
[1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester] is a sophisticated organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound, identified by its CAS number 198205-83-3, belongs to a class of molecules characterized by its biphenyl core structure adorned with carboxylic acid and trifluoromethyl substituents. The presence of these functional groups imparts unique chemical properties that make it a valuable candidate for various applications.
The molecular structure of [1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester] consists of two benzene rings connected by a methylene bridge at the para position of one ring. The carboxylic acid group at the fourth position and the trifluoromethyl groups at the third and fifth positions contribute to its high lipophilicity and metabolic stability. These characteristics are particularly advantageous in the design of bioactive molecules that require prolonged circulation times in biological systems.
In recent years, there has been a surge in research focused on developing novel compounds with enhanced pharmacological profiles. The trifluoromethyl group, in particular, is a well-known pharmacophore that can modulate the binding affinity and metabolic fate of drug candidates. Studies have shown that incorporating trifluoromethyl groups into molecular frameworks can lead to improved binding to biological targets, increased bioavailability, and reduced susceptibility to metabolic degradation.
The [1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester] molecule has been explored in several contexts within medicinal chemistry. Its biphenyl core serves as an excellent scaffold for designing molecules with specific biological activities. For instance, derivatives of this compound have been investigated for their potential as kinase inhibitors, which are crucial in treating various forms of cancer and inflammatory diseases. The electron-withdrawing nature of the trifluoromethyl groups enhances the compound's ability to interact with hydrophobic pockets of protein targets.
Recent advancements in computational chemistry have enabled researchers to predict the binding modes and affinities of such compounds with high accuracy. Molecular docking studies have revealed that [1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester] can effectively bind to active sites of enzymes and receptors involved in critical biological pathways. This has opened up new avenues for drug discovery and development.
Furthermore, the synthesis of this compound has been optimized to ensure high yields and purity. Multi-step synthetic routes have been developed that leverage modern catalytic techniques to minimize side reactions and improve overall efficiency. These synthetic strategies are essential for scaling up production and making the compound more accessible for further research.
The agrochemical industry has also shown interest in [1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester] due to its potential as a precursor for developing novel pesticides and herbicides. The structural features of this compound make it a versatile building block for designing molecules that can interact with biological targets in plants and pests. Such applications are critical for addressing the growing challenges in global food security.
In conclusion, [1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester] represents a promising compound with diverse applications in pharmaceuticals and agrochemicals. Its unique structural features and favorable chemical properties make it an attractive candidate for further exploration. As research continues to uncover new therapeutic possibilities and synthetic methodologies, this compound is poised to play a significant role in the development of next-generation bioactive molecules.
198205-83-3 ([1,1'-Biphenyl]-4-carboxylic acid, 3',5'-bis(trifluoromethyl)-, methyl ester) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)